1-8 of 8
Monica Mead, MD BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multi-Center, Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of a Novel IRAK4 Inhibitor CA-4948 in Combination with Ibrutinib, in Patients with Relapsed or Refractory Hematologic Malignancies

Grzegorz S. Nowakowski, MD, Lori A. Leslie, MD, Erel Joffe, MD MSc, Allison C. Rosenthal, D.O., Matthew A. Lunning, DO, FACP, Krish Patel, MD, Monica Mead, MD BS, Daniel J. Landsburg, MD, Timothy S. Fenske, MD, Radhakrishnan Ramchandren, Praveen Ramakrishnan Geethakumari, MD MS, Alan Skarbnik, MD, Elizabeth Martinez, PhD DHSC, MSN, Christopher Lieberman, Reinhard von Roemeling, MD, Han W. Tun, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140884
Published: 2020
Journal Articles

Impact of Comorbidities on Outcomes of Peripheral T Cell Lymphoma in Elderly Patients: An International Retrospective Study

Monica Mead, MD BS, Henrik Cederleuf, MD, Thomas Relander, MD PhD, Mats Jerkeman, MD PhD, Fredrik Ellin, MD PhD, Daria Gaut, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134814
Published: 2020
Journal Articles

Activity of Carfilzomib (CFZ) in Acute Myeloid Leukemia (AML) As a Single Agent and in Novel Combinations

Mao Yu Peng, PhD, Yasmin Abaza, MD, Martina Mcdermott, PhD, Monica Mead, MD BS, Dennis J. Slamon, MD PhD, Sarah Larson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141459
Published: 2020
Journal Articles

Phase I Dose-Escalation Trial of CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) T-Cells for the Treatment of Relapsed or Refractory B-Cell Lymphomas and Chronic Lymphocytic Leukemia

Sanaz Ghafouri, MD, Christopher Walthers, PhD, Mobina Roshandell, MS, Brenda Ji, BS, Jacqueline Trent, Jia Ming Chen, PhD, Jacob Naparstek, Monica Mead, MD BS, John M. Timmerman, MD, Yvonne Chen, Sarah Larson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-137630
Published: 2020
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Dose Optimization Efficacy Update and Expansion Phase Initial Results

Barbara Pro, MD, Jonathan E. Brammer, MD, Carla Casulo, MD, Eric Jacobsen, MD, Monica Mead, MD BS, Neha Mehta-Shah, MD, Jasmine M. Zain, MD, Pier Luigi Zinzani, MD, Stephanie Lustgarten, PhD, Hagop Youssoufian, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-140412
Published: 2020
Journal Articles

Inhibition of PI3K Alpha and PI3K Delta with Copanlisib Shows Preclinical Activity As a Single Agent and in Combination in Multiple Myeloma

Sarah M Larson, MD, Mao Yu Peng, PhD, Monica Mead, MD BS, Andrae Vandross, MD, Dylan Conklin, PhD, Erika Von Euw, PhD, Dennis J. Slamon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3084.
https://doi.org/10.1182/blood.V130.Suppl_1.3084.3084
Published: 2017
Journal Articles

Activity of the Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Copanlisib, As a Single Agent and in Combination with Carfilzomib in Multiple Myeloma

Sarah M Larson, MD, Mao Yu Peng, PhD, Andrae Vandross, MD, Monica Mead, MD BS, Zoe Fuchs, Dylan Conklin, PhD, Erika Von Euw, PhD BS, Dennis J. Slamon, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5665.
https://doi.org/10.1182/blood.V128.22.5665.5665
Published: 2016
Journal Articles

Efficacy and Mechanism of Action of the Novel Bromodomain Inhibitor, PLX51107, in B Cell Malignancies

Monica Mead, MD BS, Erika Von Euw, PhD BS, Dylan Conklin, Ben Powell, PhD BS, Kanthinh Manivong, BS, Eileen Do, Dennis J. Slamon, MDPhD, Sarah Larson, MD
Journal: Blood
Blood (2015) 126 (23): 3702.
https://doi.org/10.1182/blood.V126.23.3702.3702
Published: 2015